Tosymra Spray
Product Images NDC 0245-0812
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Tosymra (NDC 0245-0812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Tosymra 02)
Figure B (Tosymra 03)
Figure C (Tosymra 04)
Figure D (Tosymra 05)
Figure E (Tosymra 06)
Figure F (Tosymra 07)
Figure G (Tosymra 08)
Figure H (Tosymra 09)
Figure I (Tosymra 10)
Figure J (Tosymra 11)
Figure K (Tosymra 12)
Figure L (Tosymra 13)
Figure M (Tosymra 14)
Principal Display Panel (6 Bottle Blister Pack Carton)
This is a prescription drug, Sumatriptan nasal spray, used to treat migraines. This package contains six unit-dose nasal spray devices, each containing 10mg of sumatriptan in 0.1 mL, a prescribing information leaflet, and an instructions for use leaflet. It should be stored at room temperature and kept out of reach of children. The usual dosage information is provided in the package insert. Manufactured by Upsher Smith Laboratories, LLC. TOSYMRA is a registered trademark of Upsher Smith Laboratories, LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.